U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C8H17N3O2S
Molecular Weight 219.304
Optical Activity UNSPECIFIED
Defined Stereocenters 1 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of GW-274150

SMILES

CC(=N)NCCSCC[C@H](N)C(O)=O

InChI

InChIKey=MOLOJNHYNHBPCW-ZETCQYMHSA-N
InChI=1S/C8H17N3O2S/c1-6(9)11-3-5-14-4-2-7(10)8(12)13/h7H,2-5,10H2,1H3,(H2,9,11)(H,12,13)/t7-/m0/s1

HIDE SMILES / InChI

Molecular Formula C8H17N3O2S
Molecular Weight 219.304
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 1 / 1
E/Z Centers 0
Optical Activity UNSPECIFIED

GW 274150 was developed by GlaxoSmithKline as a selective inhibitor of inducible nitric oxide synthase (iNOS; also known as NOS2). Nitric oxide synthase (NOS) is an important chemical involved in the production of NO. Reduction of NOS, and therefore NO, may be an effective technique for the treatment of migraine headache. GW 274150 offered the potential of anti-inflammatory activity in migraine through a novel mechanism of action. The drug has completed phase II of the clinical trials for patients with rheumatoid arthritis and migraine disorders. In addition, GW 274150 was involved in phase I clinical trial for patients with mild asthma. However, all these studied were discontinued.

Approval Year

PubMed

PubMed

TitleDatePubMed
Role of inducible nitric oxide synthase in the reduced responsiveness of the myocardium to catecholamines in a hyperdynamic, murine model of septic shock.
2006 Feb
Patents

Sample Use Guides

90mg GW274150 will be safe and well-tolerated in this adult and elderly RA patient population on methotrexate
Route of Administration: Oral
Substance Class Chemical
Created
by admin
on Sat Dec 16 03:08:06 GMT 2023
Edited
by admin
on Sat Dec 16 03:08:06 GMT 2023
Record UNII
0ZZF1V8G63
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
GW-274150
Common Name English
L-HOMOCYSTEINE, S-(2-((1-IMINOETHYL)AMINO)ETHYL)-
Systematic Name English
GW274150
Code English
Code System Code Type Description
CAS
210354-22-6
Created by admin on Sat Dec 16 03:08:06 GMT 2023 , Edited by admin on Sat Dec 16 03:08:06 GMT 2023
PRIMARY
DRUG BANK
DB12237
Created by admin on Sat Dec 16 03:08:06 GMT 2023 , Edited by admin on Sat Dec 16 03:08:06 GMT 2023
PRIMARY
SMS_ID
300000042503
Created by admin on Sat Dec 16 03:08:06 GMT 2023 , Edited by admin on Sat Dec 16 03:08:06 GMT 2023
PRIMARY
PUBCHEM
9797017
Created by admin on Sat Dec 16 03:08:06 GMT 2023 , Edited by admin on Sat Dec 16 03:08:06 GMT 2023
PRIMARY
FDA UNII
0ZZF1V8G63
Created by admin on Sat Dec 16 03:08:06 GMT 2023 , Edited by admin on Sat Dec 16 03:08:06 GMT 2023
PRIMARY